API
< Back to all clusters
[HEALTH] · Morocco · 2 sources

started · updated

Neuropathic pain persists in RA and SpA patients on targeted therapies

A cross-sectional study conducted at the Mohammed V Military Teaching Hospital in Rabat, Morocco, has found that neuropathic pain-like features persist in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA), even when undergoing targeted therapies.

Between January and March 2026, researchers analyzed 155 patients—78 with RA and 77 with SpA—who had been receiving biologic or targeted synthetic disease-modifying antirheumatic drugs for at least six months. The study, published in Cureus, revealed that neuropathic pain-like features were present in 24.4% of RA patients and 27.3% of SpA patients.

Using screening tools such as the DN4 and painDETECT questionnaires, investigators identified symptoms like burning, tingling, and electric shock-like sensations. The findings suggest that while current treatments may effectively suppress objective inflammation, they do not always eliminate pain, highlighting a significant clinical challenge in managing chronic inflammatory rheumatic diseases.

Entities

Cureus · Mohammed V Military Teaching Hospital · Rabat